Boston Scientific Pauses Watchman FLX Sales In Europe

Boston Scientific is pausing European sales of its next-generation Watchman FLX left-atrial appendage closure device after recording a higher rate of device embolization events compared to its first-generation system.

More from Archive

More from Medtech Insight